Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Jun 11;34(176):240267.
doi: 10.1183/16000617.0267-2024. Print 2025 Apr.

Moderate-to-late prematurity: understanding respiratory consequences and modifiable risk factors

Affiliations
Review

Moderate-to-late prematurity: understanding respiratory consequences and modifiable risk factors

Kishan D Tsang et al. Eur Respir Rev. .

Abstract

As survival rates of preterm infants have increased due to advances in perinatal care, focus has shifted towards the profound long-term effects of prematurity. An extensive amount of evidence has shown increased susceptibility to chronic illnesses among preterm infants. While the onset of such conditions typically emerges during adulthood, their roots trace back to the early stages of life. Much of this interest has been directed towards short- and long-term consequences of extreme and very preterm birth. However, it has become apparent that, despite a limited risk of complications during the neonatal period, the moderate and late preterm population suffers from an increased likelihood of morbidity during the course of life. Considering the higher prevalence of moderate and late preterm births compared to extreme and very preterm births, understanding and investigating their health outcomes is essential to address the broader impact of prematurity. In this review, we will discuss the impact of moderate and late prematurity on lung development, function and how environmental factors impose these individuals to increased risk for respiratory morbidity during the course of life. We describe interventions during early life that may protect the moderate-to-late preterm population from adverse lung development and further deterioration by addressing modifiable risk factors.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: All authors report having no ethical or financial conflicts of interest related to this manuscript. K.D. Tsang reports support for the present study from BeterKeten. G.A. Tramper-Stranders reports grants from OM Pharma and AstraZeneca, participation on a data safety monitoring board or advisory board with GINSBY trial, and a leadership role with EAACI as chair of the task force on Conscious and rational use of antibiotics in allergic diseases. J.V. Been reports grants from Chiesi Pharmaceuticals. A.K. Hoffmann-Haringsma, I.K. Reiss, M.W.H. Pijnenburg and I.M. De Kleer have nothing to disclose.

Figures

FIGURE 1
FIGURE 1
The lung function development of healthy and preterm infants based on current literature. Preterm infants do not reach peak lung function by early adulthood and are potentially experiencing accelerated decline. Literature shows that lung function development is plastic and that catch-up during childhood may be possible. Alternatively, harmful exposures could result in lung function characterised by early decline and symptomatic respiratory morbidity. The first 1000 days may be a window of opportunity to allow for interventions improving respiratory health.
FIGURE 2
FIGURE 2
The preterm lung. This conceptual diagram summarises the current literature on the (potential) mechanisms involved in prematurity-associated lung disease and the effects of modifiable environmental factors on respiratory health in the preterm population. Socioeconomic deprivation modifies risk by increasing the likelihood of adverse exposures, which may work synergistically and therefore intensify their cumulative effects. At the same time, limited access to protective factors may result in poorer respiratory health. Figure created using BioRender. ROS: reactive oxygen species.

References

    1. Blencowe H, Cousens S, Oestergaard MZ, et al. National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implications. Lancet 2012; 379: 2162–2172. doi: 10.1016/S0140-6736(12)60820-4 - DOI - PubMed
    1. Luu TM, Katz SL, Leeson P, et al. Preterm birth: risk factor for early-onset chronic diseases. Can Med Assoc J 2016; 188: 736–746. doi: 10.1503/cmaj.150450 - DOI - PMC - PubMed
    1. Fisher PG. Prematurity is a chronic disease. J Pediatr 2022; 246: 1–3.
    1. Pravia CI, Benny M. Long-term consequences of prematurity. Cleve Clin J Med 2020; 87: 759–767. doi: 10.3949/ccjm.87a.19108 - DOI - PubMed
    1. Bolton CE, Bush A, Hurst JR, et al. Lung consequences in adults born prematurely. Thorax 2015; 70: 574–580. doi: 10.1136/thoraxjnl-2014-206590 - DOI - PubMed